Seqens Seqens

X

Find Radio Compass News for DSSTox_CID_3352

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
874
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.pharmacompass.com/pdf/news/b-b-pharmaceuticals-inc-receives-fda-warning-letter-1562148968.pdf

FDA
03 Jul 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2019-1560925761.pdf

FDA
19 Jun 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-25-2018-1524633895.pdf

FDA
25 Apr 2018

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pankaj-patel-owned-cadila-ups-its-india-game-with-azs-brands/articleshow/56734577.cms

ECONOMIC TIMES
24 Jan 2017

http://www.biospectrumasia.com/biospectrum/news/224613/cadila-arm-acquires-brands-msd-pharma

BIOSPECTRUM
04 Jan 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-acquires-six-brands-from-msd/articleshow/56222838.cms

ECONOMIC TIMES
29 Dec 2016

http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1101-2015&w=06032015&lang=eng

FDA
16 May 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY